THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

HRT FINANCIAL LP's Holding History (CIK: 0001475597)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 232,852 Value ($000) $4 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 23,455 Value ($000) $0 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 58,830 Value ($000) $1 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 17,490 Value ($000) $0 Avg Close $9.31 Range $8.35 - $10.90
Q2 2024
Shares 153,424 Value ($000) $1 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 131,389 Value ($000) $1 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 78,219 Value ($000) $1 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 139,898 Value ($000) $1 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 301,080 Value ($000) $3 Avg Close $11.04 Range $9.98 - $12.03
Q3 2022
Shares 49,596 Value ($000) $502 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 15,756 Value ($000) $142 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 35,289 Value ($000) $337 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 37,553 Value ($000) $414 Avg Close $8.72 Range $7.30 - $11.24
Q2 2021
Shares 16,150 Value ($000) $234 Avg Close $18.78 Range $14.46 - $22.74
Q1 2021
Shares 9,830 Value ($000) $200 Avg Close $19.01 Range $16.46 - $21.21
Q3 2020
Shares 21,083 Value ($000) $311 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 16,928 Value ($000) $355 Avg Close $25.69 Range $20.17 - $31.35